Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Mammotome secures CE mark for HydroMARK Plus, expanding breast biopsy marker access in Europe.
DHR
$215.39
+$3.65 +1.72%

Mammotome secures CE mark for HydroMARK Plus, expanding breast biopsy marker access in Europe.

Market News
04 Jun 2026
PRNewsWire
View Source
Bullish
Mammotome secures CE mark for HydroMARK Plus, expanding breast biopsy marker access in Europe.

Mammotome, a Danaher company, has received the CE mark for its HydroMARK™ Plus Breast Biopsy Site Marker. This approval allows wider access to the innovative marker technology across Europe, benefiting patients undergoing breast cancer diagnosis and treatment. The HydroMARK Plus combines proprietary hydrogel technology with features that enhance marker stability and visibility in breast care, supporting improved clinical outcomes.

More News (DHR)

Danaher names Julie Sawyer Montgomery as new CEO, effective immediately.

Danaher names Julie Sawyer Montgomery as new CEO, effective immediately.

Danaher Corporation announced that Julie Sawyer Montgomery has officially taken over as President and CEO, joining the Board of Directors as of October 1, 2026. She has been with Danaher since 2017, holding key roles in commercial operations, R&D, an...

Market News
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App